查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1928630

經經皮機械血栓切除系統市場按類型、入路、應用和最終用途分類，全球預測（2026-2032）

Percutaneous Mechanical Thrombectomy System Market by Type, Access, Application, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，經皮機械血栓切除系統市場價值將達到 20 億美元，到 2026 年將成長至 21.7 億美元，到 2032 年將達到 34.5 億美元，複合年成長率為 8.06%。

關鍵市場統計數據
基準年 2025 20億美元
預計年份：2026年 21.7億美元
預測年份 2032 34.5億美元
複合年成長率 (%) 8.06%

本書著眼於未來，介紹了正在改變經皮血栓切除術實踐的不斷發展的技術、臨床整合和跨學科動態。

經皮機械血栓切除術已成為治療方法急性和慢性血栓性疾病的重要手段，它以微創方式快速清除血栓，從而重塑了臨床實踐。此領域充分利用導管工程、抽吸和旋轉機制、雷射和超音波輔助裝置以及影像導引導航等方面的進步，在提高手術成功率的同時，最大限度地減少血管損傷。隨著手術團隊將速度和安全性放在首位，器械設計也在不斷發展，力求在血栓捕獲、管腔保留和通過迂曲血管解剖結構的輸送能力之間取得平衡，使得血栓切除術能夠應用於廣泛的血管區域。

臨床需求、器械融合和基於價值的採購如何重塑經皮血栓切除術的策略和應用

隨著器材創新、臨床證據和醫療服務期望的融合，經經皮機械血栓切除術的格局正在改變性變化。一個顯著的變化是適應症從傳統的腦血管和冠狀動脈疾病擴展到周邊血管和複雜靜脈疾病，在這些疾病中，器械的適應性和入路策略至關重要。同時，手術效率已成為關鍵的差異化因素，能夠縮短準備時間、促進快速血栓捕獲並與現有影像平台整合的系統在緊急情況下越來越受到重視。

評估近期和預期關稅調整如何影響血栓除去裝置生態系統的供應鏈韌性、籌資策略和購買行為。

源自美國的關稅政策變化對經皮機械血栓切除系統的全球供應鏈、採購決策和設備成本結構產生了連鎖反應。零件或成品進口關稅的提高迫使製造商面臨抉擇：要麼自行承擔更高的投入成本，要麼將其轉嫁給買家，要麼重組供應鏈以降低風險。每種選擇都會影響採購週期、與醫院的價格談判以及現有供應商和新進業者之間的競爭格局。為此，許多製造商正在增加近岸外包，並實現供應商多元化，以減少對單一國家的依賴，並穩定生產計劃。

透過詳細的細分分析進行戰術性定位，將設備需求與應用領域、技術等級、臨床環境和准入策略連結起來。

深入了解產品和臨床策略需要理解器械在應用、系統類型、最終使用環境和血管通路技術方面的定位。根據應用的不同，治療路徑涵蓋了多種類型，包括針對頸動脈狹窄的頸動脈介入治療、針對非ST段抬高型心肌梗塞（Non-STEMI）和ST段抬高型心肌梗塞（STEMI）的冠狀動脈介入治療、專門針對缺血性卒中的神經血管治療，以及針對深層靜脈栓塞症和周邊動脈疾病的外周介入治療。如此多樣化的應用催生了不同的器械規格、手術流程和培訓需求。例如，腦循環介入治療優先考慮微導管的操控性，而周邊介入治療則強調其在大血管血栓切除術中的穩健性。

區域衛生系統、報銷環境和基礎設施成熟度如何導致全球主要區域採用路徑的差異

區域趨勢在經皮機械血栓切除技術的研發、應用和報銷中起著至關重要的作用。在美洲，完善的臨床網路和高度普及的先進介入治療基礎設施支援創新系統的快速應用。然而，報銷機制和醫院採購週期會影響技術的採用時間和規模。相較之下，歐洲、中東和非洲地區（EMEA）的醫療保健模式多種多樣，集中採購和國家指南在某些市場加速了技術的普及，而在其他市場則延長了普及進程。監管協調和跨境臨床合作是該地區的關鍵促進因素。

塑造血栓清除領域競爭格局的策略性企業行動：定向創新、臨床支援計畫和夥伴關係的主導組合拓展

透過各公司活動的檢驗，可以發現構成血栓切除系統競爭格局的幾個策略主題。領先的醫療設備製造商和專業創新企業正在採取差異化策略，將產品改進、擴展的臨床證據和服務相結合，以深化與醫院的合作關係。一些公司專注於改進導管幾何形狀和抽吸效率，以縮短手術時間並提高首次手術成功率；而另一些公司則投資於混合系統，將機械作用與基於能量的血栓修飾相結合，以應對更複雜的阻塞情況。對臨床醫生培訓計畫和模擬教育的策略性投資對於支持技術應用、縮短學習曲線以及促進醫療機構的廣泛採用至關重要。

為製造商和醫療系統提供可操作的策略重點，以加速產品推廣應用、控制成本壓力並使產品開發與臨床需求保持一致。

為了使技術進步與臨床需求和採購實踐相契合，產業領導者應圍繞以下可操作的優先事項制定策略。首先，透過投資多學科臨床證據，證明設備在關鍵適應症（例如頸動脈狹窄、急性冠狀動脈症候群、缺血性中風、深層靜脈栓塞症和周邊動脈疾病）中的性能，從而贏得不同手術團隊的信任。其次，優先考慮產品的模組化和互通性，透過與現有成像和支援平台無縫整合，降低採用門檻。第三，積極拓展供應來源，並考慮本地化生產和組裝，以降低關稅風險並縮短前置作業時間。

本研究的調查方法明確說明為混合方法，結合了臨床醫生訪談、技術設備分析和臨床文獻綜合，以確保得出可靠的結論。

本分析所依據的研究整合了對關鍵相關人員的訪談、設備層面的技術審查、同行評審的臨床研究以及對專業學會指南的嚴格評估。主要資料來源包括對介入醫師、醫院採購人員和設備技術人員的結構化訪談，以了解實際操作中的限制、採購考慮和性能預期。這些觀點與臨床文獻的系統性回顧相結合，以評估相對安全性、首次手術成功率以及對血管外科各學科手術流程的影響。

總之，這項綜合性綜述強調了關鍵因素（設備性能、臨床證據和供應彈性）的匯聚，這些因素共同塑造了未來血栓切除術的普及。

經經皮機械血栓切除術正處於策略轉折點，器械創新、臨床證據和醫療保健系統優先事項在此交匯，共同決定未來的治療路徑。無論適應症如何，重點在於實現更安全、更快速、更可重複的手術，成功的解決方案將結合高效能的器械、精簡的工作流程和強大的臨床支援。穩健的供應鏈、監管合作和本地化的商業化計劃對於確保在各種醫療機構中持續可及和廣泛應用至關重要。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 經經皮機械血栓切除系統市場（按類型分類）

  • 吸力系統
  • 雷射系統
  • 旋轉系統
  • 超音波系統

第9章 經經皮機械血栓切除系統市場（以入路方式分類）

  • 肱動脈路
  • 股動脈路徑
  • 橈動脈入路

第10章經皮機械血栓切除系統市場（依應用分類）

  • 頸動脈
  • 冠狀動脈
    • 非ST段抬高型心肌梗塞
    • ST段上升型心肌梗塞
  • 神經血管
  • 外圍
    • 深層靜脈栓塞症
    • 周邊動脈疾病

第11章 經經皮機械血栓切除系統市場（依最終用途分類）

  • 門診手術中心
  • 診所
  • 醫院

第12章經皮機械血栓切除系統市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章經皮機械血栓切除系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國經經皮機械血栓切除系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國經皮機械血栓切除系統市場

16. 中國經皮機械血栓切除系統市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Acandis GmbH & Co. KG
  • AngioDynamics, Inc.
  • Balt Extrusion SAS
  • Boston Scientific Corporation
  • Cook Medical, Inc.
  • Edwards Lifesciences Corporation
  • Inari Medical, Inc.
  • Johnson & Johnson
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroVention, Inc.
  • Penumbra, Inc.
  • phenox GmbH
  • Rapid Medical, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vesalio, LLC
Product Code: MRR-92740D85F07B

The Percutaneous Mechanical Thrombectomy System Market was valued at USD 2.00 billion in 2025 and is projected to grow to USD 2.17 billion in 2026, with a CAGR of 8.06%, reaching USD 3.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.00 billion
Estimated Year [2026] USD 2.17 billion
Forecast Year [2032] USD 3.45 billion
CAGR (%) 8.06%

A forward-looking introduction to the evolving technology, clinical integration, and interdisciplinary dynamics transforming percutaneous thrombectomy practice

Percutaneous mechanical thrombectomy has emerged as a critical intervention across acute and chronic thrombotic conditions, reshaping clinical practice by enabling rapid clot removal with minimally invasive approaches. The field draws on advances in catheter engineering, aspiration and rotational mechanics, laser and ultrasonic adjuncts, and imaging-guided navigation to improve procedural success while minimising vessel trauma. As procedural teams prioritize speed and safety, device designs have evolved to balance clot engagement, lumen preservation, and deliverability through tortuous anatomy, making thrombectomy techniques applicable across a broad spectrum of vascular territories.

Contemporary practice demands integrated solutions that harmonize device performance with workflow efficiency, from pre-procedural imaging to post-procedural recovery. This imperative has driven cross-disciplinary collaboration among interventional cardiology, neurointerventional, vascular surgery, and interventional radiology communities. Consequently, evidence generation has focused on patient selection criteria, comparative safety profiles, and real-world procedural metrics, informing clinical guidelines and hospital adoption. Looking forward, ongoing refinements in materials science, catheter profiles, and adjunctive pharmacology are expected to enhance the therapeutic index of percutaneous mechanical thrombectomy and to expand its role within both acute stroke pathways and peripheral vascular interventions.

How intersecting clinical demands, device convergence, and value-based procurement are reshaping percutaneous thrombectomy strategies and adoption

The landscape for percutaneous mechanical thrombectomy is undergoing transformative shifts as device innovation, clinical evidence, and care-delivery expectations converge. One prominent change is the broadening of indications beyond traditional cerebrovascular and coronary settings into peripheral and complex venous territories, where device adaptability and access strategies matter greatly. At the same time, procedural efficiency has become a primary differentiator; systems that reduce setup time, facilitate rapid clot engagement, and integrate with existing imaging platforms are increasingly favored in high-acuity environments.

Technological convergence is also notable. Hybrid designs that combine aspiration with mechanical fragmentation, or integrate ultrasonic energy to augment clot disruption, are redefining performance benchmarks. Alongside device evolution, payer and provider emphasis on value-based care is reshaping procurement decisions, prompting manufacturers to demonstrate not only clinical effectiveness but also downstream impact on length of stay, readmissions, and rehabilitation needs. Finally, the rise of modular ecosystems-where catheters, guidewires, and support platforms are designed for seamless compatibility-reflects a system-level shift toward interoperability, repeatable procedural workflows, and clinician-centric user experiences.

Assessing how recent and prospective tariff adjustments are influencing supply chain resilience, sourcing strategies, and procurement behavior in thrombectomy device ecosystems

Tariff policy changes originating from the United States have a cascading influence on global supply chains, sourcing decisions, and device cost structures for percutaneous mechanical thrombectomy systems. When import duties increase on components or finished devices, manufacturers confront immediate choices: absorb higher input costs, pass them through to purchasers, or restructure supply chains to mitigate exposure. Each option carries implications for procurement cycles, pricing negotiations with hospitals, and the competitive landscape among established vendors and new entrants. In response, many manufacturers pursue nearshoring or diversify supplier bases to limit single-country dependencies and to stabilize production timelines.

Beyond direct input costs, tariff adjustments can affect the cadence of clinical trials and international regulatory filings when key components or system modules originate from affected regions. Delays in component availability may slow product iterations and limit the rollout of software-enabled upgrades that rely on integrated hardware. Healthcare providers can experience indirect impacts as procurement teams recalibrate capital equipment budgets, prioritizing devices with locally sourced components or longer service lifecycles. In combination, these dynamics encourage collaboration between manufacturers and hospital systems to structure long-term supply agreements, hedge against tariff volatility through contractual clauses, and invest in supply chain transparency. Such measures preserve access to critical thrombectomy devices while offering predictability for clinical programs and capital planning.

Deep-dive segmentation insights linking application-specific device requirements, technology classes, clinical environments, and access strategies for tactical positioning

Insight into product and clinical strategy requires an understanding of how devices are positioned across applications, system types, end-use environments, and vascular access approaches. Based on application, therapeutic pathways span carotid artery interventions focused on carotid stenosis, coronary procedures addressing both Non-STEMI and STEMI presentations, neurovascular treatment specifically oriented to ischemic stroke, and peripheral interventions for deep vein thrombosis and peripheral arterial disease. This range of applications drives distinct device specifications, procedural workflows, and training demands, as cerebral circulation procedures prioritize microcatheter maneuverability while peripheral interventions emphasize robustness for large-vessel thrombus extraction.

Based on type, the technology landscape includes aspiration systems, laser systems, rotational systems, and ultrasonic systems, each offering different mechanisms for clot engagement and fragmentation. Device selection is influenced by thrombus composition, anatomical constraints, and procedural objectives, with aspiration systems often favored for soft thrombus and rotational or laser solutions considered for more organized occlusions. Based on end use, the mix of ambulatory surgical centers, clinics, and hospitals shapes procurement criteria; hospitals handle the highest-acuity cases and require integrated imaging and hybrid operating environments, whereas ambulatory and clinic settings prioritize rapid turnover and standardized procedural kits. Based on access, clinicians rely on brachial access, femoral access, and radial access depending on anatomical reach, complication profiles, and operator preference, and access strategy informs training, ancillary equipment needs, and post-procedural monitoring protocols.

How regional healthcare systems, reimbursement landscapes, and infrastructure maturity create distinct adoption pathways across major global territories

Regional dynamics play a pivotal role in how percutaneous mechanical thrombectomy technologies are developed, adopted, and reimbursed. In the Americas, established clinical networks and a high prevalence of advanced interventional infrastructure favor rapid adoption of innovative systems, while reimbursement frameworks and hospital procurement cycles influence the timing and scale of deployments. In contrast, Europe, Middle East & Africa encompasses diverse healthcare models where centralized procurement and national-level guideline development can accelerate uptake in some markets while creating longer adoption curves in others; regulatory harmonization and cross-border clinical collaborations are important enablers in this region.

Asia-Pacific presents a mix of rapidly modernizing healthcare systems, large patient populations, and an expanding base of locally manufactured technologies that can compete on cost and bespoke design. Across all regions, differences in procedural volumes, clinician training pathways, and infrastructure maturity shape device preferences and support models. While global clinical evidence informs practice universally, regional reimbursement policies, referral patterns, and hospital capital planning introduce local variance in adoption trajectories and in the competitive strategies manufacturers pursue to gain traction.

Strategic corporate behaviors shaping the thrombectomy competitive field through targeted innovation, clinical support programs, and partnership-driven portfolio expansion

A review of company activity highlights several strategic themes defining the competitive environment for thrombectomy systems. Leading medical device firms and specialist innovators are pursuing differentiated approaches that combine product refinement, expanded clinical evidence, and service offerings to deepen hospital relationships. Some companies concentrate on refining catheter geometry and aspiration efficiency to reduce procedure time and increase first-pass success rates, while others invest in hybrid systems that pair mechanical action with energy-based clot modification to address tougher occlusions. Strategic investments in clinician training programs and simulation-based education have become essential to support adoption, reducing learning curves and enabling broader use across institutional settings.

Mergers, acquisitions, and partnership models remain common as device manufacturers seek to augment portfolios with complementary technologies, software-enabled imaging integrations, and market access capabilities. Aftermarket services such as field-based technical support, warranty structures, and consumable management are increasingly central to commercial discussions, given hospitals' focus on predictable total cost of ownership. Finally, companies that provide clear evidence of device safety across multiple vascular territories and that demonstrate compatibility with common access strategies often secure stronger clinical endorsements, facilitating inclusion in care protocols and procurement frameworks.

Practical strategic priorities for manufacturers and health systems to accelerate adoption, manage cost pressures, and align product development with clinical demand

Industry leaders should orient strategy around several actionable priorities that align technological progress with clinical needs and procurement realities. First, invest in cross-disciplinary clinical evidence that demonstrates device performance across the key application areas-carotid stenosis, coronary acute coronary syndromes, ischemic stroke, deep vein thrombosis, and peripheral arterial disease-to build credibility with diverse procedural teams. Second, prioritise product modularity and interoperability so devices integrate smoothly with prevailing imaging platforms and support platforms, thereby reducing adoption friction. Third, proactively diversify supply sources and consider localized manufacturing or assembly to mitigate tariff exposure and to shorten lead times for customers.

Equally important is the enhancement of clinician training and procedural simulation offerings to accelerate skill uptake and to reduce variability in outcomes. Commercially, adopting flexible pricing constructs, outcome-linked contracting, and bundled purchasing options can align vendor incentives with hospital priorities and support procurement approvals. Finally, engage with regulatory bodies and payer stakeholders early to clarify real-world evidence requirements and reimbursement pathways, ensuring that commercialization timelines reflect both clinical validation and reimbursement readiness.

Transparent description of the mixed-methods research approach combining clinician interviews, technical device analysis, and clinical literature synthesis to ensure robust conclusions

The research underpinning this analysis synthesizes primary stakeholder interviews, device-level technical review, and a rigorous appraisal of peer-reviewed clinical studies and professional society guidance. Primary inputs included structured interviews with interventional clinicians, hospital procurement leaders, and device engineers to capture real-world procedural constraints, procurement considerations, and performance expectations. Those perspectives were integrated with a systematic review of clinical literature to assess comparative safety profiles, first-pass success narratives, and procedural workflow implications across vascular territories.

Complementing qualitative insights, a technical analysis of device architectures and mechanism-of-action classifications-aspiration, laser, rotational, and ultrasonic-provided a basis for evaluating suitability across thrombus types and access strategies. Supply chain and policy analyses examined component sourcing, tariff exposures, and manufacturing footprint considerations to surface resilience strategies. Throughout, findings were triangulated to ensure consistency between clinical imperatives, engineering constraints, and commercial realities, yielding conclusions that are directly actionable for device developers, hospital system leaders, and strategic investors.

Concluding synthesis emphasizing the critical convergence of device performance, clinical evidence, and supply resilience shaping future thrombectomy adoption

Percutaneous mechanical thrombectomy stands at a strategic inflection point where device innovation, clinical evidence, and health system priorities intersect to determine future pathways of care. Across anatomical indications, the emphasis is on achieving safer, faster, and more reproducible procedures, and successful solutions will be those that reconcile high-performance mechanics with streamlined workflows and robust clinician support. Supply chain resilience, regulatory engagement, and regionally informed commercialization plans will be essential to sustain access and to enable widespread adoption across varied healthcare settings.

Ultimately, stakeholders who align product development with clinician needs, invest in rigorous evidence generation, and structure commercial models that address hospital fiscal constraints will be best positioned to influence care protocols and to capture long-term clinical endorsement. By focusing on modular design, interoperability, and comprehensive training programs, manufacturers can lower barriers to adoption and contribute meaningfully to improved patient outcomes across neurovascular, coronary, carotid, and peripheral vascular domains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Mechanical Thrombectomy System Market, by Type

  • 8.1. Aspiration Systems
  • 8.2. Laser Systems
  • 8.3. Rotational Systems
  • 8.4. Ultrasonic Systems

9. Percutaneous Mechanical Thrombectomy System Market, by Access

  • 9.1. Brachial Access
  • 9.2. Femoral Access
  • 9.3. Radial Access

10. Percutaneous Mechanical Thrombectomy System Market, by Application

  • 10.1. Carotid Artery
  • 10.2. Coronary
    • 10.2.1. Non Stemi
    • 10.2.2. Stemi
  • 10.3. Neurovascular
  • 10.4. Peripheral
    • 10.4.1. Deep Vein Thrombosis
    • 10.4.2. Peripheral Arterial Disease

11. Percutaneous Mechanical Thrombectomy System Market, by End Use

  • 11.1. Ambulatory Surgical Center
  • 11.2. Clinic
  • 11.3. Hospital

12. Percutaneous Mechanical Thrombectomy System Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Percutaneous Mechanical Thrombectomy System Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Percutaneous Mechanical Thrombectomy System Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Percutaneous Mechanical Thrombectomy System Market

16. China Percutaneous Mechanical Thrombectomy System Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Acandis GmbH & Co. KG
  • 17.7. AngioDynamics, Inc.
  • 17.8. Balt Extrusion S.A.S.
  • 17.9. Boston Scientific Corporation
  • 17.10. Cook Medical, Inc.
  • 17.11. Edwards Lifesciences Corporation
  • 17.12. Inari Medical, Inc.
  • 17.13. Johnson & Johnson
  • 17.14. LeMaitre Vascular, Inc.
  • 17.15. Medtronic plc
  • 17.16. Merit Medical Systems, Inc.
  • 17.17. MicroVention, Inc.
  • 17.18. Penumbra, Inc.
  • 17.19. phenox GmbH
  • 17.20. Rapid Medical, Inc.
  • 17.21. Stryker Corporation
  • 17.22. Teleflex Incorporated
  • 17.23. Terumo Corporation
  • 17.24. Vesalio, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ASPIRATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ASPIRATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ASPIRATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ROTATIONAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ROTATIONAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ROTATIONAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ULTRASONIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ULTRASONIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ULTRASONIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY BRACHIAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY BRACHIAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY BRACHIAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY FEMORAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY FEMORAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY RADIAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY RADIAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CAROTID ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CAROTID ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CAROTID ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NON STEMI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NON STEMI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NON STEMI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY STEMI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY STEMI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY STEMI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 130. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 133. GCC PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 151. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 154. G7 PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 158. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 161. NATO PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY ACCESS, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA PERCUTANEOUS MECHANICAL THROMBECTOMY SYSTEM MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)